Dermapharm Holding SE (ETR:DMP)
Germany · Delayed Price · Currency is EUR 43.00
+1.25 (2.99%)
Jul 29, 2026, 4:36 PM CET
Dermapharm Holding SE Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,068 | 2,119 | 2,094 | 2,280 | 2,020 | 4,808 | |
Market Cap Growth | 9.60% | 1.16% | -8.13% | 12.85% | -57.98% | 56.78% |
Enterprise Value | 2,878 | 2,964 | 2,957 | 3,207 | 2,386 | 5,229 |
Last Close Price | 43.00 | 39.35 | 38.90 | 42.34 | 37.52 | 89.30 |
PE Ratio | 15.58 | 16.00 | 18.44 | 36.50 | 15.07 | 22.96 |
Forward PE | 15.36 | 15.94 | 16.66 | 17.44 | 10.61 | 22.27 |
PEG Ratio | 1.71 | 1.77 | 0.54 | 1.22 | 1.22 | 1.22 |
PS Ratio | 1.75 | 1.82 | 1.77 | 2.01 | 1.97 | 5.10 |
PB Ratio | 2.81 | 3.05 | 3.47 | 4.23 | 3.80 | 9.67 |
P/FCF Ratio | 8.59 | 11.33 | 12.84 | 12.82 | 8.10 | 25.42 |
P/OCF Ratio | 7.26 | 9.25 | 10.40 | 10.39 | 7.00 | 19.20 |
EV/Sales Ratio | 2.43 | 2.54 | 2.50 | 2.82 | 2.33 | 5.55 |
EV/EBITDA Ratio | 8.89 | 9.48 | 9.73 | 11.27 | 7.05 | 14.79 |
EV/EBIT Ratio | 12.43 | 13.43 | 13.63 | 17.54 | 9.79 | 17.52 |
EV/FCF Ratio | 11.95 | 15.85 | 18.12 | 18.03 | 9.56 | 27.64 |
Debt / Equity Ratio | 1.25 | 1.34 | 1.46 | 1.77 | 0.96 | 1.15 |
Debt / EBITDA Ratio | 3.21 | 3.37 | 3.23 | 3.80 | 1.53 | 1.64 |
Debt / FCF Ratio | 4.32 | 5.63 | 6.01 | 6.07 | 2.07 | 3.07 |
Net Debt / Equity Ratio | 1.10 | 1.22 | 1.42 | 1.71 | 0.69 | 0.84 |
Net Debt / EBITDA Ratio | 2.51 | 2.72 | 2.83 | 3.24 | 1.08 | 1.19 |
Net Debt / FCF Ratio | 3.38 | 4.54 | 5.26 | 5.18 | 1.47 | 2.21 |
Asset Turnover | 0.52 | 0.55 | 0.56 | 0.64 | 0.73 | 0.72 |
Inventory Turnover | 1.08 | 1.14 | 1.31 | 1.51 | 1.50 | 1.48 |
Quick Ratio | 0.93 | 0.92 | 0.68 | 0.63 | 1.14 | 1.51 |
Current Ratio | 2.00 | 2.05 | 1.82 | 1.60 | 2.45 | 3.34 |
Return on Equity (ROE) | 20.10% | 20.22% | 19.38% | 11.24% | 25.69% | 50.68% |
Return on Assets (ROA) | 7.62% | 7.40% | 6.65% | 5.85% | 10.60% | 16.18% |
Return on Invested Capital (ROIC) | 11.00% | 10.51% | 9.61% | 8.83% | 16.45% | 24.61% |
Return on Capital Employed (ROCE) | 12.43% | 12.27% | 12.33% | 12.35% | 19.92% | 25.48% |
Earnings Yield | 6.97% | 6.25% | 5.42% | 2.74% | 6.64% | 4.36% |
FCF Yield | 11.64% | 8.83% | 7.79% | 7.80% | 12.35% | 3.93% |
Dividend Yield | 2.11% | 2.29% | 2.26% | 2.48% | 5.78% | 0.99% |
Payout Ratio | 33.60% | 36.59% | 41.64% | 90.64% | 87.04% | 22.61% |
Buyback Yield / Dilution | 0.04% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Shareholder Return | 2.15% | 2.29% | 2.26% | 2.48% | 5.78% | 0.99% |